Andrii Lovin

Andrii Lovin

Auto-generated profile, based on publicly available information

Andrii Lovin

Taras Shevchenko National University of Kyiv, Kyiv, Ukraine

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 June 2023 in INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine)
Verified
Journal Article
Open access
PDF file
ADAndrii Dinets
Andrii Dinets
MGM. Gorobeiko
M. Gorobeiko
VHV. Hoperia
V. Hoperia
ALA. Lovin
A. Lovin
STS. Tarasenko
S. Tarasenko
Background. Papillary thyroid carcinoma (PTC) is the most frequent malignant neoplasm originating from follicular cells of thyroid gland. PTC is often coexisting with other benign thyroid pathology such as chronic lymphocytic thyroiditis, follicular thyroid adenoma, toxic thyroid adenoma, Graves’ disease, non-toxic multinodular goiter. PTC can be diagnosed in patients undergoing surgical treatment for hyperparathyroidism. However, the clinical and pathomorphological features of PTC in the presence of other benign thyroid or parathyroid pathology, as well as possible differences in surgical tactics, remain relevant as evidenced by previously published reports. The purpose of the study is to assess the prevalence and determine the differences in the clinical and pathomorphological parameters of PTC in the presence of benign thyroid and parathyroid pathology. Materials and methods. There were identified 91 patients with PTC, who underwent surgical treatment at the clinical bases of the Department of Surgery of the NSC “Institute of Biology and Medicine” of Taras Shevchenko National University of Kyiv. Results. In the studied PTC cohort, 31 (35 %) patients were without coexisted benign thyroid pathology and 60 (35 %) patients had it (PTC/coexisted). A statistically significantly higher number of mitoses per 10 high power fields in the PTC group were identified in 3 (10 %) patients, as compared to the absence of this pathohistological parameter in the PTC/coexisted (p = 0.037). Further analysis of these 3 cases showed that 4 mitotic figures were found in one PTC, and one mitotic figure in the other two cases per 10 high power fields (400×). Conclusions. Papillary thyroid carcinoma in patients with other benign thyroid pathology is associated with lower biological aggressiveness than PTC without comorbidity as evidenced by a lower frequency of mitotic figures per 10 high power fields. The presence of concomitant benign thyroid pathology can be considered as a favorable prognostic factor for patients with PTC.

30 September 2023 in Endokrynologia
Verified
Journal Article
Open access
PDF file
MGM.B. Gorobeiko
M.B. Gorobeiko
ADAndrii Dinets
Andrii Dinets
VHV.H. Hoperia
V.H. Hoperia
YPYu.M. Pysmenna
Yu.M. Pysmenna
ALA.V. Lovin
A.V. Lovin
KAK.M. Abdalla
K.M. Abdalla
Папілярна карцинома щитоподібної залози (ПКЩЗ) є частим злоякісним новоутворенням щитоподібної залози. ПКЩЗ розміром 1 см або менше в найбільшому діаметрі класифікується як мікрокарцинома (ПМКЩЗ). До 10% ПМКЩЗ мають біологічно агресивний перебіг, що проявляється інвазивними характеристиками пухлини (інвазія кровоносних судин, лімфатичних судин, периневральна інвазія, поява фігур мітозів), рецидивом карциноми, які є параметрами, які важко передбачити, але які суттєво впливають на прогноз перебігу хвороби. Мета. Дослідити та оцінити клінічні та гістопатологічні особливості ПМКЩЗ порівняно з ПКЩЗ. Матеріал і методи. Виявлено 91 хворого на ПКЩЗ, які проходили оперативне лікування на клінічних базах кафедри хірургії ННЦ «Інститут біології та медицини» Київського національного університету ім. Тараса Шевченка. У досліджуваній когорті з 91 пацієнта в 50 (85%) хворих діагностовано ПМКЩЗ, у 41 (15%) — ПКЩЗ. Результати. Інвазію в лімфатичні судини достовірно рідше діагностували в 15 (30%) пацієнтів у групі ПМКЩЗ порівняно з 24 (58%) пацієнтами в групі ПКЩЗ (p<0,005). Також у групі ПМКЩЗ не було діагностовано жодного випадку периневральної інвазії карциноми, що достовріно нижче порівняно з 4 (10%) пацієнтами в групі ПКЩЗ (p<0,005). Подальший аналіз патоморфологічних даних також показав статистично значущу різницю між даними макроскопічної та мікроскопічної інвазії карциноми. Мікроскопічна екстратиреоїдна інвазія карциноми рідше виявлялася в пацієнтів групи ПМКЩЗ – 2 (4%) хворих, порівняно з 12 (29%) пацієнтами у групі ПКЩЗ (p<0,005). Макроскопічна екстратиреоїдна інвазія діагностувалась значно рідше в пацієнтів групи ПМКЩЗ в 1 (2%) пацієнта, порівняно з 9 (22%) пацієнтами в групі ПКЩЗ (p<0,005). Висновки. ПМКЩЗ виявляє нижчу біологічну агресивність, ніж ПКЩЗ, про що свідчать нижча частота мікроскопічної та макроскопічної інвазії, периневральної інвазії та лімфатичної інвазії. Мікрокарциному можна вважати більш сприятливим прогностичним фактором для пацієнтів із ПКЩЗ.

30 June 2025 in Inter Collegas
Verified
Journal Article
Open access
PDF file
ADAndrii Dinets
Andrii Dinets
ILI. Lurin
I. Lurin
MGM. Gorobeiko
M. Gorobeiko
VHV. Hoperia
V. Hoperia
KAK. Abdalla
K. Abdalla
ALA. Lovin
A. Lovin
Background. Papillary Thyroid Carcinoma (PTC) is the most frequently diagnosed malignant neoplasm of the endocrine system, accounting for more than 80% of other histopathological types of thyroid cancer worldwide, including Ukraine. Both overweight (Body Mass Index (BMI) [25.0–29.9] kg/m2) and obesity (BMI >30 kg/m2) might be considered a risk factor for PTC development. Besides, it may be associated with negative clinical characteristics such as obesity and overweight or biological aggressiveness of PTC such as larger tumor size, invasion to thyroid structures or adjacent neck tissues, metastatic spread etc., which are not sufficiently studied in Ukraine. Aim. To investigate and evaluate the features of the overweight and obesity in the patients with PTC and compare them with patients with PTC and normal weight. Materials and Methods. Our study involved 91 patients with the diagnosis of PTС who underwent surgical treatment at Verum Expert Clinic (Kyiv, Ukraine). The study groups consisted of 65 patients with PTС and overweight/obesity (BMI ≥25 kg/m2), and 26 patients with PTС and normal weight. Written informed consent to participate was obtained from all patients, and the study was approved by the local ethical committee. The non-parametric Mann-Whitney U test was applied to compare quantitative variables between groups. Categorical variables were compared using Fisher's exact test (two-tailed). Statistica 12 (TIBCO Software Inc., USA) and Graph­Pad Prism 10 (GraphPad Software, LLC, USA) statistical software were used for data analyses. Statistical significance was set at p<0.05. Results. A statistically significant difference was found in the frequency of lateral neck dissection: it was performed in 12 (46%) patients with PTC and normal weight, compared to 22 (34%) patients with PTC and overweight/obesity (p=0.031). Conclusions. Overweight and obesity are highly prevalent among patients with PTC in our cohort. However, the higher rate of lateral neck dissection in the normal-weight group suggests that factors other than BMI, possibly related to preoperative diagnosis, played a more critical role in surgical planning in this study. Keywords: cancer risk, lymph node excision, neoplasm invasiveness, body mass index, thyroid neoplasms, risk factors.

15 November 2023 in General Surgery
Verified
Journal Article
Open access
PDF file
ADAndrii Dinets
Andrii Dinets
MGM. Gorobeiko
M. Gorobeiko
YPY. Pysmenna
Y. Pysmenna
ALA. Lovin
A. Lovin
KAK. Abdalla
K. Abdalla
VHV. Hoperia
V. Hoperia
Papillary thyroid carcinoma (PTC) is characterized by various clinical and pathomorphological features, such as metastases to the locoregional lymph nodes and radioiodine resistance. It could also be diagnosed as a microcarcinoma coexisting with other benign thyroid pathologies or as multifocal growth. Of these, multifocality in PTC is considered an unfavourable pathomorphological feature. However, the research findings are controversial. Objective — to investigate and evaluate the clinical and pathohistological features of multifocal PTC (mPTC) in comparison with unifocal (single nodule) PTC. Materials and methods. Among the patients who underwent operative treatment at the clinical bases of the Department of Surgery, Institute of Biology, and Medicine at Taras Shevchenko National University of Kyiv, 91 were diagnosed with PTC and were included in the study. Results. Out of the 91 patients, 31 (34%) had mPTC and 60 (66%) had PTC. Bilateral mPTC was diagnosed in 23 (74%) patients, which is in line with other studies. It is also worth mentioning, that 5 (16%) patients were diagnosed with multifocal growth only at the stage of histopathology section, without preoperative or intraoperative evidence of multifocality. A significantly higher frequency of locoregional metastasis was found in the mPTC group in 17 (55%) patients as compared to 18 (30%) patients with PTC (p=0.025). Lateral neck dissection was performed in 13 (42%) patients with mPTC, and in 13 (22%) patients with PTC (р=0.0525). Frozen section pathology was performed in 17 (24 patients with mPTC, and in 4 (10%) patients with PTC (р >0,05). Conclusions. A higher frequency of locoregional metastasis and a higher propensity for performing a lateral neck dissection are both indicators of a higher biological aggressiveness of the carcinoma in PTC multifocal growth.

30 June 2025 in Experimental and Clinical Medicine
Verified
Journal Article
Open access
PDF file
ADAndrii Dinets
Andrii Dinets
ILI. Lurin
I. Lurin
MGM. Gorobeiko
M. Gorobeiko
VHV. Hoperia
V. Hoperia
КАК.м. Абдалла
К.м. Абдалла
АЛА.в. Льовін
А.в. Льовін
Papillary Thyroid Carcinoma (PTC), a well-differentiated malignant neoplasm originating from thyroid follicular cells, has been increasingly studied for its association with obesity. In Ukraine, PTC accounts for approximately [1.7–1.8]% of all malignant tumors. Accumulated evidence suggests that obesity, characterized by a Body Mass Index (BMI) over 30 kg/m2, promotes carcinogenesis through hormonal changes, chronic inflammation, oxidative stress, and insulin resistance. The aim of the study was to investigate the relationship of obesity or overweight with PTC size. This retrospective study examined 91 patients with histologically confirmed PTC, categorizing them based on BMI into normal weight, overweight, and obese groups. Patients were divided into groups in relation to their weight. The study group comprised patients with overweight and obesity based on their BMI. Informed consent was obtained from all participants. Statistica 12 (TIBCO Software Inc., USA) and GraphPad Prism 10 (GraphPad Software, LLC, USA) statistical software were used for data analyses. Statistical significance was set at p<0.05. The study showed that in our cohort, 71% of PTC patients were overweight or obese. Notably, larger tumors (≥1 cm) were more common in obese and overweight groups, whereas PTC microcarcinomas (<1 cm) were more frequent in patients with normal weight, suggesting a potential correlation between obesity and larger tumor size (p<0.05). This size differential suggests that metabolic factors associated with higher BMI may influence tumor growth in PTC. The results of the study indicate that PTC with a tumor diameter of ≥1 cm is more likely in obese and overweight patients. Thyroid microcarcinomas are more common in patients of normal weight. Obesity can be considered as a risk factor for faster growth of neoplasms in PTC. Keywords: papillary thyroid microcarcinoma, cancer risk, body mass index, neoplasm staging, prognostic factors, morphometric parameters.

30 June 2025 in Medicine Today and Tomorrow
Verified
Journal Article
Open access
PDF file
ADAndrii Dinets
Andrii Dinets
ILI. Lurin
I. Lurin
MGM. Gorobeiko
M. Gorobeiko
VHV. Hoperia
V. Hoperia
КАК.м. Абдалла
К.м. Абдалла
АЛА.в. Льовін
А.в. Льовін
Background. Papillary Thyroid Carcinoma (PTC) is the malignant neoplasm of thyroid gland constituting up to 80% of all thyroid cancer types. The relationship between PTC and obesity is not well investigated in Ukraine. Aim. To investigate and evaluate the features of the microscopic invasive features of PTC in the obese and overweight patients and compare it with patients with PTC and normal weight. Materials and Methods. This study enrolled 91 patients who were diagnosed with PTC. The patients were divided into a groups depending on their Body Mass Index (BMI): 20 patients with PTC and obesity (BMI >30 kg/m2), the 45 patients with overweight and PTC (BMI [24.0–29.0] kg/m2) and 26 patients with PTC and normal weight (BMI [18.0–23.9] kg/m2). A clinical data and histopathological parameters were retrieved from archived medical records. Written informed consent was to participated was obtained from all patient. Statistica 12 (TIBCO Software Inc., USA) and GraphPad Prism 10 (GraphPad Software, LLC, USA) statistical software were used for data analyses. Statistical significance was set at p<0.05. Ethical approval for the study was obtained the local ethical committee at Verum Expert Clinic. The study was conducted according to Helsinki Declaration and Ukrainian ethical standards. Results. A statistically significant difference in the higher frequency of microscopic damage to the thyroid gland structures by PTC was detected in 6 (30.0%) patients with PTC with obesity, in 3 (6.0%) patients with PTC with overweight, and in 5 (19.0%) patients with PTC with normal weight (p=0.046). Further data analysis revealed a significantly higher frequency of the PTC perineural invasion in 3 (15%) obese patients with PTC, in 3 (2.2%) overweight patients with PTC, and in none of the patients with PTC and normal weight (p=0.031). Conclusions. Patients with PTC and obesity have 1.57 higher frequency of microscopic invasion predominately due to perineural invasion of the carcinoma, which is aggressive biological characteristics of malignant neoplasm. The risk of PTC in the population with obesity should be taken into consideration by medical professional, and aggressive biological characteristics should be considered at follow up and management of the patients. Keywords: neoplasm invasiveness, perineural invasion, body mass index, cancer risk factors.